共 10 条
[1]
P rognostic in form a-tion prov ided by seria lm easurem en ts of bra in natriuretic peptidein heart fa ilure. Bettencourt P,F rioes F,A zevedo A,et a l. In t J C ard io l . 2004
[2]
Cardiac natriuretic peptide for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. Selvais PL,Donckier JE,Robert A,et al. European Journal of Clinical Investigation . 1998
[3]
A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. Cheng V,Kazanagra R,Garcia A,et al. Journal of the American College of Cardiology . 2001
[4]
BNP as a biomarker in heart disease. Vuolteenaho O,Ala-Kopsala M,Ruskoaho H. Advances in Clinical Chemistry . 2005
[5]
Brain natriuretic peptide as bridge to therapy for heart failure. Dries,D.L.,Stevenson,L.W. The Lancet . 2000
[6]
Diastolic dysfunction and natriuretic peptides in systolic heart failure, Higher ANP and BNP levels are associated with the restrictive filling pattern. Yu C M,Sanderson J E,Shum I Q, et al. European Heart Journal . 1996
[7]
Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Maeda K,Takayoshi T,Wada A,et al. American Heart Journal . 1998
[8]
UtilityofarapidB natriureticpeptideassayindifferentiatingcongestiveheartfailurefromlungdiseaseinpatientspresentingwithdyspnea. MorrisonLK,HarrisonA,KrishnaswamyP,etal. Journal of the American College of Cardiology . 2002
[9]
G u idelines for the d iagnosisand treatm en t of chron ic heart fa ilure. T ask force for the d iagnosis and treatm en t of chron ic heart fa ilureof European.Society of card io logy. European Heart Journal . 2001
[10]
R elationsh ip betw een re-na l function and p lasm a bra in natriuretic peptide in patien ts w ithheart fa ilure. T su tam oto T,,W ada A,Saka iH,et a l. J Am C o ll C ard io l . 2006